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To study the outcome of botulinum toxin (BTX) treatment (group 1) in partially accommoda-
tive esotropia with high accommodative convergence/accommodation (AC/A) ratio, in com-
parison with bilateral medial rectus muscles recessions and posterior fixation (group 2).
Methods
In a retrospective comparative study, children aged 3–8 years old treated between 2011
and 2016, with partially accommodative esotropia with high AC/A ratio, deviation at distance
of 10 prism diopters or more, and at least 1 year of follow-up, were included. Visual acuity,
alternate prism and cover test, stereoacuity, biomicroscopy, and cycloplegic retinoscopy
were carried out at initial, baseline visit, 6 months and 1 year after BTX injection or surgery.
Main outcome variables were deviation at distance and near, improvement in stereoacuity,
and percentage of success. We used multiple regression or proportional odds analysis to
control for potential confounding variables.
Results
Of 95 patients, 84 were eligible, 48 children in group 1 and 36 in group 2. Deviation and
stereoacuity were similar in the two groups at 6 months, but significantly better in the BTX
group at 1 year (median distance deviation 0 prism diopters vs 5 prism diopters, p<0.01),
although differences were not clinically relevant. Percentage of success was also signifi-
cantly better only at 1 year (93% vs 72%, p = 0.01). Change in distance-near disparity was
not significantly different in the two groups in the period of study.
Conclusions
Botulinum toxin could be superior to, or as effective as surgery, at middle term, in the treat-
ment of partially accommodative esotropia with high AC/A ratio.
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Introduction
In children with accommodative esotropia type high accommodative convergence/accommo-
dation ratio, correction of hyperopia may control deviation at distance, with persistent devia-
tion at near, but in some patients yet there is residual deviation at distance with glasses on
(partially accommodative). When distance deviation equals or exceeds 10 prism diopters
(PD), our aim is to align eyes at distance with additional procedures, several of which are avail-
able. Surgery is directed to operate for the near angle[1], for the average of near and distant
angles measured with the distance correction, or added recession to standard surgical dosages.
[2] Another option is to recess medial rectus muscles and add posterior fixation (fadenopera-
tion) to facilitate control of deviation at near.[3–5] We had used the latter procedure for sev-
eral years, whereas botulinum toxin injection in the medial rectus muscles was not considered
a primary indication for this condition. However, we had to use botulinum toxin in some
cases, in particular when parents did not agree to surgery. The results obtained using botuli-
num toxin were considered to be satisfactory. Consequently, we started to treat children using
this therapy more frequently. In this study, our purpose was to investigate the results of botuli-
num toxin (BTX) (group 1) compared to bilateral medial rectus muscles recessions with poste-
rior fixation (group 2) in treating partially accommodative esotropia with high AC/A ratio.
Methods
We retrospectively reviewed the charts of children aged 3–8 years old with the diagnosis of
partially accommodative esotropia with high AC/A ratio made between 2011 and 2016 (search
in the electronic clinical record system). At a significance level of 0.05, detectable difference of
10 PD, standard deviation of 12 PD, and power of 80%, a sample size of n = 26 was required in
each group. The study was approved by the Institutional UAM Ethics Committee (MINECO
UAMA13-4E-2192) and adhered to the tenets of the Declaration of Helsinki. After a detailed
explanation of the nature of the study, informed consent was obtained for BTX injection or
surgery, and for collection of the relevant data.
Distance glasses were prescribed at initial evaluation (full cycloplegic refraction). Esodevia-
tion measured with distance correction after 2 months of wearing glasses full time (baseline
visit), was used for eligibility. Children with residual esotropia were re-refracted before addi-
tional intervention was indicated. Two children in the surgery group, and three in the botuli-
num group required new full plus glasses prescription for 2 months before a decision was
taken. Children who had esotropia at distance of at least 10 PD, and an increase in deviation
by 10 PD or more for near as compared to distance, and underwent surgery by recession of
medial rectus muscles and posterior fixation suture (surgery) or botulinum toxin injection in
medial rectus muscles (BTX) were eligible. AC/A ratio was determined using a lens gradient
method with +3.00 D lenses at near (the difference between deviation without and with the
+3.00 D lens was divided by 3 to obtain the AC/A ratio; AC/A ratio > 5 was considered high).
For inclusion, at least 1 year of follow up after intervention (surgery or BTX) was required.
After explanation of the nature, side effects, and characteristics of the two procedures, we
offered the family the option of botulinum toxin injection or surgery, and the procedure was
decided in agreement with parents. Bifocal add was contemplated only after intervention
when deviation at near persisted. Smallest power of bifocals required for orthotropia at near
was prescribed. Parents were informed that bifocals reduced or eliminated deviation at near,
but that existing data didn’t show clear benefit in bifocal wearing, or at least its use was
controversial.
Children with the diagnosis of eye disease, previous eye surgery, myopia greater than -0.50
D, or follow-up of less than 1 year after intervention were excluded from the analysis.
Botulinum toxin in high AC/A ratio esotropia
PLOS ONE | https://doi.org/10.1371/journal.pone.0229267 February 28, 2020 2 / 9
collection and analysis, decision to publish, or
preparation of the manuscript
Competing interests: The authors have declared
that no competing interests exist.
Clinical evaluation included measurement of visual acuity (logMAR HOTV or electronic
ETDRS, depending on chidren’s ability to cooperate; a level was considered passed when at least
three of four letters were identified correctly), stereoacuity at near (Randot preschool or Randot
stereotests–circles with random dot ground, Stereo Optical Inc, Chicago), deviation angle at dis-
tance (6 m) and near (35 cm) by alternate prism and cover test, and fusion (Bagolini, Worth four
dot). Cycloplegic retinoscopy, as well as anterior and posterior segment routine examination were
also part of the study in each follow-up visit. Stereoacuity was tranformed to log arc seconds, and
prism deviation to degrees, for statistical analysis. To enable calculation of changes in stereoacuity,
if the patient had no measurable stereoacuity, the next log level above the largest disparity for the
test was assigned (in 0.3 log arcsec progression, 6000 arcsec, i.e. 3.78 log arcsec). This is a com-
monly used strategy in analysis of stereoacuity data.[6,7] We defined amblyopia as a difference of
at least 2 logMAR lines in visual acuity between the two eyes. Patching (2 to 6 hours per day
depending on clinician’s judgement) was used for the treatment of amblyopia.
We injected 2.5 to 3 IU of Botulinum toxin in both medial rectus muscles (group 1) or did
recession of both medial rectus muscles for an average deviation between distance and near
(AAO surgical guidelines for esodeviation[8]) with posterior fixation (group 2). Recessions of
medial rectus muscles ranged between 3 and 4.5 mm. Posterior fixation was done at 13–14
mm from the muscle insertion, at approximately the location of the muscle pulley. Although
this was identified during surgery, we nevertheless chose to use a classical scleral fixation tech-
nique to secure the muscle, with a nonabsorbale 5–0 Dacron suture, and not a modified pulley
fixation technique, as described by Clark et al.[5]
We employed linear multiple regression, when the distribution of variables was compatible
with normality, or proportional odds, when the distribution was not normal, to control for
potential confounders. Preintervention variables included in the stepwise multivariate analysis
(we controlled for) were age, sex, refraction, baseline deviation (at distance and near with dis-
tance correction), lines of difference in visual acuity between the two eyes, and stereoacuity.
We also used unpaired t test (with Bonferroni correction to manage potential error for multi-
ple comparisons) and Chi-square test. Values obtained in the analysis, were reconverted to the
original scale, for a more familiar notation to the clinician. Graphical representation of variable
distribution and Shapiro-Wilk test were used to test for normality.
The primary outcome variable was deviation at distance and near, change in distance-near
disparity, and success (defined as deviation at distance� 8 DP and fusion at near) at 6 months
and 1 year. A secondary outcome variable was improvement in stereoacuity.
Results
Of 95 children, 84 were eligible, and 11 were excluded due to short follow-up (2), insufficient
data (6), or myopia (3). Power of the statistical analyses done in this study was at least 80%. All
patients wore glasses when hyperopic of� 1.50 D, until evaluation 2 months after initial visit
(2-month visit was considered baseline visit). Baseline characteristics of children included are
summarized in Table 1. We did not find differences between the two treatment groups except
for refraction, which was slightly larger in the botulinum group.
Botulinum toxin injection or surgery was indicated, after explanation of the nature, advan-
tages and disadvantages of the procedures, when deviation at distance of at least 10 PD, and at
least 10 PD greater at near, was observed in the baseline visit. We were in favor of doing sur-
gery but when parents were reluctant, or taking into consideration that surgery required more
time of general anesthesia and was more invasive, botulinum toxin injection was chosen.
Amblyopia was treated, when present, for no more than 4 months before intervention (botuli-
num or surgery), so intervention was not delayed.
Botulinum toxin in high AC/A ratio esotropia
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Six months after Botox injection or surgery, the deviation (with distance glasses) at distance
and near, as well as stereoacuity, were similar in the two groups. However, the deviations in
the surgery group were significantly larger and stereoacuity in the BTX group significantly bet-
ter at 1 year (see Table 2 and Figs 1 and 2). Some variable differences at 6 months were near
significance (e.g., difference in distance deviation and stereoacuity). Most differences encoun-
tered at 6 or 12 months, being significant or not, were of little clinical relevance, because they
were in the limits of reproducibility of the prism and alternate cover test.[7]
Change in distance-near disparity was not significantly different between the botulinum
and surgery group at 6 months (median 6.6 deg [12 PD], range 0–8.8 deg [0–16 PD] and 4.8
deg [9 PD], range 0–8.8 [0–16 PD], respectively; p = 0.05) and 12 months (median 6.6 deg [12
PD] range 0–8.8 deg [0–16 PD] and 5.4 deg [10 PD], range 3.1–8.8 deg [6–16 PD] respectively;
p = 0.14).
Percentage of success (defined as deviation at distance� 8 DP and fusion at near with
Bagolini lenses/Worth four dot) was similar at 6 months in the botulinum and surgery group
(45 of 48 [93.7%], and 31 of 36 [86.1%], respectively, p = 0.23) but smaller in the surgery group
at 1 year (45 of 48 [93.7%], and 26 of 36 [72.2%], respectively, p = 0.01). The odds in favor of
success of the botulinum group was 2.4 times that of the surgery group at 6 months (95%
CI:0–2.5), and 5.7 times at 1 year (95% CI:1.4–22.8) (see Table 3). Apparently, the slight trend
Table 2. Motor outcome after surgery or botulinum toxin injection.
Botulinum toxin Surgery p
Deviation at 6 months (median [range])
Distance
Degrees 0 [0–4.5] 2.3 [0–5.7] 0.05
Prism Diopters 0 [0–8] 4 [0–10]
Near
Degrees 2.3 [0–9] 4.5 [0–10] 0.15
Prism Diopters 4 [0–16] 8 [0–18]
Deviation at 12 months (median [range])
Distance
Degrees 0 [0–3.4] 2.8 [0–6.8] 0.01
Prism Diopters 0 [0–6] 5 [0–12]
Near
Degrees 2.2 [0–6.8] 4.5 [0–7.9] 0.03
Prism Diopters 4 [0–12] 8 [0–14]
https://doi.org/10.1371/journal.pone.0229267.t002
Table 1. Characteristics of patients included†.
Preintervention variables BTX (n = 48) Surgery (n = 36) p
Age (years) 5 (3–8) 5 (3–8) 0.9
Refraction (diopters) 3 (2.25–5) 2.75 (2.25–3.25) <0.01
Distance deviation (deg) 6.8 (5.7–11.3) 8.5 (5.7–13.5) 0.07
Near deviation (deg) 15.6 (11.3–16.7) 15.6 (13.5–19.8) 0.4
logMAR lines of difference 0 (0–3) 0 (0–3) 0.3
Stereoacuity (log arc sec) 2.9 (2.6–3.78) 2.9 (2.6–3.78) 0.7
Sex (female)‡ 26/48 54.2 19/36 52.8 0.8
†Median (min-max) except for sex variable
‡proportion
https://doi.org/10.1371/journal.pone.0229267.t001
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toward recurrence of deviation was larger in the surgery group. Four patients in the botulinum
group and 3 patients in the surgery group required change (additional plus) in refraction at 6
months, whereas 5 patients in the botulinum and 4 in the surgery group required new glasses
prescription at one year.
Percentage of bifocal use was significantly lower in the botulinum toxin than in the surgery
group (8 of 48 [17%] vs 14 of 36 [39%], respectively, p = 0.02). The odds in favor of using bifo-
cals in the surgery group was 3 times (95% CI:1.1–8.7) that of the botulinum group (Table 3).
Frequency of a new procedure during the year of study follow-up (surgery, when deviation at
distance was greater than 8 PD), was similar in the two groups (3 of 48 in the botulinum group
[6.2%]) vs 7 of 36 in the surgery group [19.4%], p = 0.09). Two of these children in the
Fig 1. Motor outcome at 6 and 12 months. Boxplot showing deviation at distance and near (degrees) at 6 months (A,C) and 12 months (B,D) after botulinum toxin or
surgical treatment. Deviation was similar in the two treatment groups group at 6 months, but was smaller in the botulinum group at 1 year, although differences were
not of remarkable clinical relevance. The bottom and top of each box represent the 25th and 75th percentiles (the lower and upper quartiles), respectively; the solid line
band in the box is the median (50th percentile). The upper whisker is the smaller of the 75th percentile plus 1.5 times the interquartile range (IQR) or the maximum
value. The lower whisker is the larger of the 25th percentile minus 1.5 times the IQR or the minimum value.
https://doi.org/10.1371/journal.pone.0229267.g001
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PLOS ONE | https://doi.org/10.1371/journal.pone.0229267 February 28, 2020 5 / 9
botulinum group and 3 in the surgery group were prescribed additional hyperopic correction
before indication of reintervention. Three of the 10 ‘unsuccessful result’ patients in the surgery
group were not reoperated because deviation at distance was 10 PD, but it was not apparent,
and they were able to fuse at near.
We used multivariate analysis to identify significant predictors of outcome variables (see
Table 4). Significant predictors of deviation and success at 12 months were treatment modality
and lines of difference in visual acuity between the two eyes, respectively. A significant predic-
tor of deviation and success at 6 months was deviation before intervention.
Discussion
We have studied the outcome of patients with partially accommodative esotropia with high
AC/A ratio who required treatment for deviation at distance and near, treated with botulinum
toxin. We used patients treated by bilateral medial rectus muscles recessions and posterior fix-
ation, during approximately the same period of time, as a control group. We did not conduct a
randomized controlled trial due to the relatively small number of children with these charac-
teristics that we treated every year, thus a multicenter study would be required.
Percentage of success, deviation and stereoacuity were not significantly different in the two
groups at 6 months, although difference in some variables almost reached significance. The
Fig 2. Stereoacuity outcome at 6 and 12 months. Boxplot showing stereoacuity (log arc seconds) at 6 months (A) and 12 months (B) after botulinum toxin or surgical
treatment. Stereoacuity was similar in the two treatment groups group at 6 months, but was better in the botulinum group at 1 year, although differences were not of
particular clinical relevance. The bottom and top of each box represent the 25th and 75th percentiles (the lower and upper quartiles), respectively; the solid line band in
the box is the median (50th percentile). The upper whisker is the smaller of the 75th percentile plus 1.5 times the interquartile range (IQR) or the maximum value. The
lower whisker is the larger of the 25th percentile minus 1.5 times the IQR or the minimum value.
https://doi.org/10.1371/journal.pone.0229267.g002
Table 3. Odds of failure and bifocal use.
Variable BTX† Surgery† Odds ratio
Failure at 6 m 3/48 6.2 (-0.5–13.1) 5/36 13.9 (2.5–25.1) 2.4 (0–2.5)
Failure at 12 m 3/48 6.2 (-0.5–13.1) 10/36 27.8 (13.1–42.4) 5.7 (1.4–22.8)
Bifocal use 8/45 16.7 (6.1–27.2) 14/36 38.9 (22.9–54.8) 3.1 (1.1–8.7)
†Proportion (95% CI)
https://doi.org/10.1371/journal.pone.0229267.t003
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differences observed became significant at 12 months, in favor of the botulinum toxin group.
The stereoacuity levels may have been related to the duration of alignment before the constant
esotropia developed, but it was not studied because this information was not always available.
However, the clinical relevance of differences reported may be considered low, because differ-
ences in deviation are in the limit of reproducibility of prism and alternate cover test.[9]
Notwithstanding, the reported percentage of success, as defined in the present study, was
higher in the botulinum group at middle term. Apparently, there was a slight trend toward
increasing deviation in the surgery group. Loss of effect with time could be explained by the
technique we used for posterior fixation, i.e., the classical technique of muscle scleral fixation,
but done immediately anterior to the level of the muscle pulley, which is located in a coronal
plane just behind the equator of the globe.[10] Posterior fixation in our cases was done at
approximately 13–14 mm from the insertion, and we used nonabsorbable suture to minimize
undercorrection. We had no overcorrections in either study group. In the past while perform-
ing 0.5 to 1 mm larger recessions combined with posterior fixation we had overcorrections.
These frequently increased with time and required reoperation. In the present study we thus
adhered strictly to the AAO guidelines.[8]
A limitation of the present investigation is that data were collected retrospectively, so there
is potential bias in treatment assignment and patient selection. However, differences were not
observed in pretreatment characteristics between the two groups, except for refraction. A dif-
ference of 0.25 D in spherical equivalent is not considered of clinical significance.
In this study, the odds in favor of successful result was greater in the botulinum group, and
the odds in favor of using bifocal, in the surgery group. But reintervention was not indicated
with significantly greater frequency in the surgery compared with the botulinum group. Good
apparent aesthetic result and detectable binocularity were factors in favor of discarding rein-
tervention in limit cases (with distance deviation of approximately 10 PD), which could con-
tribute to similar frequency of reintervention.
Interestingly, not only treatment modality and initial deviation were significant predictor
variables on deviation after treatment and success, but also lines of difference in visual acuity
between the two eyes, particularly at one year of follow-up. In theory, amblyopia could have
influence on the result of surgery, recurrence of deviation, distance-near disparity, and binocu-
lar vision.
We believe that the apparent superiority of botulinum toxin at middle term, could be due
to unnoticed bias, and specific surgical technique. A justification for more conservative (i.e.,
less posterior) scleral fixation of the medial rectus muscles is the risk of overcorrection with
time that experts have frequently described in association with fadenoperation, in particular
when combined with medial rectus recession.[1,3] According to our previous experience,
Table 4. Predictors for each outcome variable.
Outcome Variable Significant predictor variables p
Deviation at distance 6 m (deg) Preintervention distance deviation 0.001
Deviation at distance 12 m (deg) Treatment 0.001
Lines of difference <0.001
Deviation at near 6 m (deg) Preintervention near deviation <0.001
Deviation at near 12 m (deg) Treatment 0.002
Lines of difference <0.001
Success at 6 m Preintervention near deviation <0.001
Success at 12 m Treatment 0.013
Lines of difference 0.006
https://doi.org/10.1371/journal.pone.0229267.t004
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increasing the amount of medial rectus recessions involves greater risk of overcorrection with
time at distance, although motor success results could improve at short term. The results at
near could be better with a more posterior placement of posterior fixation. Although in theory
there is no significant effect of this procedure on deviation at distance, fadenoperation has
been mentioned as a contributing factor to distance overcorrection when combined with mus-
cle recession. However, as mentioned above, more recent studies demonstrate that the effect of
posterior fixation is stable at long term.[11]
Conclusions
To summarize, we found that botulinum toxin could be superior to, or at least as effective as,
surgery, at middle term, in the treatment of partially accommodative esotropia with high AC/
A ratio. Although this is a relatively surprising finding, botulinum toxin appears as a useful
therapeutic alternative in this type of strabismus, with remarkable results in binocularity. A
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